Bio-Rad Laboratories Inc (BIO): רווח למניה בשנים עשר החודשים האחרונים
Bio-Rad Laboratories (BIO) maintains a global network of plants across Asia, Europe, and the US, ensuring the stable production of reference reagents. The TTM net income per share reflects the impact of this manufacturing capacity, and the figure is currently fixed at 37.60. Business resilience is based on the integration of closed diagnostic systems and low geopolitical risks, which guarantees uninterrupted global supplies.
פילוחים אנליטיים ודוחות נתונים של חברת Bio-Rad Laboratories, Inc. (BIO)
The EPS (TTM) metric expresses the portion of net income attributable to each common share per year, which allows the financial result to be stripped of the impact of share issuance. A high proportion of consumables sales within the Bio-Rad Laboratories (BIO) structure guarantees stable cash flows, confirming the asset's fundamental value through the current level of rolling earnings per share.
